Delivery Order SPE2DB22D2206-SPE2DB24FJV57

Award Date 8/16/24
Potential Completion Date 9/9/24
Potential Value $47K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product AYVAKIT 25 MG TABLET 30S. The contract has a ceiling value of $23,325.68 and is a firm-fixed-price contract. The period of performance extends through October 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,368.92 firm fixed-price delivery order is for the provision of AYVAKIT 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves...
This federal contract award, valued at $24,131.83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AYVAKIT 25 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 22, 2025. The contract was awarded on December 30, 2024 and was not designated as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AYVAKIT 25 MG TABLET 30S. The contract is a firm-fixed price delivery order with a ceiling value of $23,325.68 and an ultimate completion date of October 17, 2024. This contract is not set aside for any particular business type. Amerisourcebergen, through its Corporate Office Division, has been awarded multiple...
This is a federal contract award from the Defense Logistics Agency (DLA) to the pharmaceutical distributor Amerisourcebergen Drug Corp. The contract, with a ceiling value of $24,368.92, is for the delivery of AYVAKIT 25 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,325.68, is for the delivery of AYVAKIT 25 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 12, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $23,325.68, is for the supply of the pharmaceutical product AYVAKIT 25 MG TABLET 30S. This award is a part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and effective through December 31, 2025. The IDC serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the specialty medication AYVAKIT 25 MG TABLET 30S, with a ceiling value of $23,325.68 and a period of performance through August 29, 2024. The contract is a firm fixed-price Delivery Order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a firm fixed price delivery order contract between the Defense Logistics Agency (DLA) Troop Support Medical and the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of AYVAKIT 25 MG TABLET 30S, a specialty pharmaceutical product, with a potential value of $23,325.68 and a performance period through March 1, 2024. This delivery order...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which runs through December 31, 2025, enables DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJV57
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical supplier, for the provision of AYVAKIT 25 MG TABLET 30S. The contract has a firm fixed price of $46,651.36 and an ultimate completion date of September 9, 2024. This award is associated with a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/15/24, 9:24 AM